(Q48119068)

8 February 2018

title

Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children (English)

1 reference

8 February 2018

1 reference

2

1 reference

8 February 2018

author name string

B-J Ko

1

1 reference

8 February 2018

K H Park

3

1 reference

8 February 2018

H S Park

4

1 reference

8 February 2018

C S Mantzoros

5

1 reference

8 February 2018

language of work or name

English

0 references

publication date

18 March 2014

1 reference

8 February 2018

International Journal of Obesity

published in

1 reference

8 February 2018

volume

38

1 reference

8 February 2018

issue

12

1 reference

8 February 2018

page(s)

1497-1502

1 reference

8 February 2018

https://scigraph.springernature.com/pub.10.1038/ijo.2014.45

exact match

0 references

cites work

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

An update on the prevalence of the metabolic syndrome in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: the Bogalusa Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Plasma selenium in specific and non-specific forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Purification of selenoprotein P from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

A liver-derived secretory protein, selenoprotein P, causes insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

S-adenosylmethionine-dependent protein methylation is required for expression of selenoprotein P and gluconeogenic enzymes in HepG2 human hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

The FGF family: biology, pathophysiology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Circulating fibroblast growth factors as metabolic regulators--a critical appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Circulating Fibroblast Growth Factor-23 Is Associated With Fat Mass and Dyslipidemia in Two Independent Cohorts of Elderly Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

FGF23 contributes to insulin sensitivity in obese adolescents - preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Serum adipocyte fatty acid-binding protein, retinol-binding protein 4, and adiponectin concentrations in relation to the development of the metabolic syndrome in Korean boys: a 3-y prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Involvement of selenoprotein P in protection of human astrocytes from oxidative damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Both maximal expression of selenoproteins and selenoprotein deficiency can promote development of type 2 diabetes-like phenotype in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Epidemiology of selenium and type 2 diabetes: can we make sense of it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

The relationship between selenoprotein P and glucose metabolism in experimental studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Longitudinal changes in risk variables of insulin resistance syndrome from childhood to young adulthood in offspring of parents with type 2 diabetes: The Bogalusa Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Association of exonic variants of Klotho with metabolic syndrome in Asian Indians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Effects of Long-Term Selenium Supplementation on the Incidence of Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2014.45

Involvement of selenoprotein P in the regulation of redox balance and myofibroblast viability in idiopathic pulmonary fibrosis

21 January 2018

1 reference

12 December 2020

Metabolic syndrome and all-cause mortality: a meta-analysis of prospective cohort studies

1 reference

12 December 2020

The insulin-like effects of selenate in rat adipocytes

1 reference

12 December 2020

Carotid Artery Stiffness in Obese Children With the Metabolic Syndrome

1 reference

12 December 2020

Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis

1 reference

12 December 2020

Comment on the provisional report from the WHO consultation

1 reference

12 December 2020

Identifiers

DOI

10.1038/IJO.2014.45

1 reference

8 February 2018

1 reference

8 February 2018